{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:54:27Z","timestamp":1792598067137,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"DOI":"10.1007\/s40615-026-03224-3","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:16:49Z","timestamp":1792595809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Racial and Geographic Disparities in Co-Documented Prostate Cancer and Hypertension Mortality Among U.S. Men, 1999\u20132024: A Multiple Cause of Death Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4868-0220","authenticated-orcid":false,"given":"Kanza","family":"Atif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7010-6910","authenticated-orcid":false,"given":"Eshal","family":"Atif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5588-9892","authenticated-orcid":false,"given":"Vishan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9275-8022","authenticated-orcid":false,"given":"Sadia","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1588-3909","authenticated-orcid":false,"given":"Muhammad Atif","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3201-8341","authenticated-orcid":false,"given":"Aziz","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"6","key":"3224_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3322\/caac.70028","volume":"75","author":"TB Kratzer","year":"2025","unstructured":"Kratzer TB, Mazzitelli N, Star J, Dahut WL, Jemal A, Siegel RL. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025;75(6):485\u201397. https:\/\/doi.org\/10.3322\/caac.70028.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3224_CR2","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1186\/s12889-025-25694-6","volume":"25","author":"Z Chai","year":"2025","unstructured":"Chai Z, Yan S, Li H, Dong X, Li S, Fan Y, et al. Temporal trends and regional disparities in prostate cancer mortality in the United States, 1999\u20132023: an analysis of the CDC WONDER database. BMC Public Health. 2025;25(1):4263. https:\/\/doi.org\/10.1186\/s12889-025-25694-6.","journal-title":"BMC Public Health"},{"issue":"1","key":"3224_CR3","doi-asserted-by":"publisher","first-page":"e2456825","DOI":"10.1001\/jamanetworkopen.2024.56825","volume":"8","author":"EL Van Blarigan","year":"2025","unstructured":"Van Blarigan EL, McKinley MA, Washington SL 3rd, Cooperberg MR, Kenfield SA, Cheng I, et al. Trends in prostate cancer incidence and mortality rates. JAMA Netw Open. 2025;8(1):e2456825. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.56825.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"3224_CR4","doi-asserted-by":"publisher","first-page":"e2211869","DOI":"10.1001\/jamanetworkopen.2022.11869","volume":"5","author":"L Burgess","year":"2022","unstructured":"Burgess L, Aldrighetti CM, Ghosh A, Niemierko A, Chino F, Huynh MJ, et al. Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer-specific mortality. JAMA Netw Open. 2022;5(5):e2211869. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11869.","journal-title":"JAMA Netw Open"},{"issue":"18","key":"3224_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","volume":"319","author":"DC Grossman","year":"2018","unstructured":"US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, et al. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(18):1901\u201313. https:\/\/doi.org\/10.1001\/jama.2018.3710.","journal-title":"JAMA"},{"key":"3224_CR6","doi-asserted-by":"publisher","first-page":"1130691","DOI":"10.3389\/fcvm.2023.1130691","volume":"10","author":"Z Luo","year":"2023","unstructured":"Luo Z, Chi K, Zhao H, Liu L, Yang W, Luo Z, et al. Cardiovascular mortality by cancer risk stratification in patients with localized prostate cancer: a SEER-based study. Front Cardiovasc Med. 2023;10:1130691. https:\/\/doi.org\/10.3389\/fcvm.2023.1130691.","journal-title":"Front Cardiovasc Med"},{"issue":"48","key":"3224_CR7","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehz766.","journal-title":"Eur Heart J"},{"issue":"7","key":"3224_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/cncr.22933","volume":"110","author":"CS Saigal","year":"2007","unstructured":"Saigal CS, Gore JL, Krupski TL, Hanley J, Schonlau M, Litwin MS. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer. 2007;110(7):1493\u2013500. https:\/\/doi.org\/10.1002\/cncr.22933.","journal-title":"Cancer"},{"issue":"3","key":"3224_CR9","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/j.clgc.2022.12.006","volume":"21","author":"J Swaby","year":"2023","unstructured":"Swaby J, Aggarwal A, Batra A, Jain A, Seth L, Stabellini N, et al. Association of androgen deprivation therapy with metabolic disease in prostate cancer patients: an updated meta-analysis. Clin Genitourin Cancer. 2023;21(3):e182\u20139. https:\/\/doi.org\/10.1016\/j.clgc.2022.12.006.","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"3224_CR10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","volume":"121","author":"GN Levine","year":"2010","unstructured":"Levine GN, D\u2019Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association. Circulation. 2010;121(6):833\u201340. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192695.","journal-title":"Circulation"},{"issue":"41","key":"3224_CR11","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology. Eur Heart J. 2022;43(41):4229\u2013361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244.","journal-title":"Eur Heart J"},{"issue":"62","key":"3224_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/jncimonographs\/lgad018","volume":"2023","author":"R Gulati","year":"2023","unstructured":"Gulati R, Nyame YA, Lange JM, Shoag JE, Tsodikov A, Etzioni R. Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors. J Natl Cancer Inst Monogr. 2023;2023(62):212\u20138. https:\/\/doi.org\/10.1093\/jncimonographs\/lgad018.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"21","key":"3224_CR13","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/cncr.34433","volume":"128","author":"JW Lillard Jr","year":"2022","unstructured":"Lillard JW Jr, Moses KA, Mahal BA, George DJ. Racial disparities in Black men with prostate cancer: a literature review. Cancer. 2022;128(21):3787\u201395. https:\/\/doi.org\/10.1002\/cncr.34433.","journal-title":"Cancer"},{"issue":"7","key":"3224_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","volume":"5","author":"RT Dess","year":"2019","unstructured":"Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, et al. Association of Black race with prostate cancer-specific and other-cause mortality. JAMA Oncol. 2019;5(7):975\u201383. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0826.","journal-title":"JAMA Oncol"},{"issue":"3","key":"3224_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaccao.2024.04.004","volume":"6","author":"BG Demissei","year":"2024","unstructured":"Demissei BG, Ko K, Huang A, Lee DJ, Doucette AG, Smith AM, et al. Social determinants of health mediate racial disparities in cardiovascular disease in men with prostate cancer. JACC CardioOncol. 2024;6(3):390\u2013401. https:\/\/doi.org\/10.1016\/j.jaccao.2024.04.004.","journal-title":"JACC CardioOncol"},{"issue":"1","key":"3224_CR16","doi-asserted-by":"publisher","first-page":"e007917","DOI":"10.1161\/CIRCOUTCOMES.121.007917","volume":"15","author":"Z Javed","year":"2022","unstructured":"Javed Z, Maqsood MH, Yahya T, Amin Z, Acquah I, Valero-Elizondo J, et al. Race, racism, and cardiovascular health: applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2022;15(1):e007917. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.121.007917.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"3224_CR17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","volume":"130","author":"TM Powell-Wiley","year":"2022","unstructured":"Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, et al. Social determinants of cardiovascular disease. Circ Res. 2022;130(5):782\u201399. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319811.","journal-title":"Circ Res"},{"issue":"5","key":"3224_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.amepre.2018.01.021","volume":"54","author":"WE Zahnd","year":"2018","unstructured":"Zahnd WE, Fogleman AJ, Jenkins WD. Rural-urban disparities in stage of diagnosis among cancers with preventive opportunities. Am J Prev Med. 2018;54(5):688\u201398. https:\/\/doi.org\/10.1016\/j.amepre.2018.01.021.","journal-title":"Am J Prev Med"},{"issue":"6","key":"3224_CR19","doi-asserted-by":"publisher","first-page":"e70812","DOI":"10.1002\/cam4.70812","volume":"14","author":"C Liu","year":"2025","unstructured":"Liu C, Samson KK, Shats O, Bergan R. Disparities between rural and urban patients with prostate cancer in Nebraska. Cancer Med. 2025;14(6):e70812. https:\/\/doi.org\/10.1002\/cam4.70812.","journal-title":"Cancer Med"},{"key":"3224_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2307\/2626958","volume":"Spec No","author":"BG Link","year":"1995","unstructured":"Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;Spec No:80\u201394. https:\/\/doi.org\/10.2307\/2626958.","journal-title":"J Health Soc Behav"},{"issue":"3","key":"3224_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/002214650404500303","volume":"45","author":"JC Phelan","year":"2004","unstructured":"Phelan JC, Link BG, Diez-Roux A, Kawachi I, Levin B. Fundamental causes of social inequalities in mortality: a test of the theory. J Health Soc Behav. 2004;45(3):265\u201385. https:\/\/doi.org\/10.1177\/002214650404500303.","journal-title":"J Health Soc Behav"},{"issue":"3","key":"3224_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/EDE.0000000000001597","volume":"34","author":"K Bishop","year":"2023","unstructured":"Bishop K, Balogun S, Eynstone-Hinkins J, Moran L, Martin M, Banks E. Analysis of multiple causes of death: a review of methods and practices. Epidemiology. 2023;34(3):333\u201344. https:\/\/doi.org\/10.1097\/EDE.0000000000001597.","journal-title":"Epidemiology"},{"key":"3224_CR23","doi-asserted-by":"publisher","first-page":"100499","DOI":"10.1016\/j.ahjo.2025.100499","volume":"50","author":"AMK Minhas","year":"2025","unstructured":"Minhas AMK, Sperling LS, Al-Kindi S, Abramov D. Underlying and contributing causes of mortality from CDC WONDER: insights for researchers. Am Heart J Plus. 2025;50:100499. https:\/\/doi.org\/10.1016\/j.ahjo.2025.100499.","journal-title":"Am Heart J Plus"},{"issue":"1","key":"3224_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canep.2011.07.004","volume":"36","author":"AK Fink","year":"2012","unstructured":"Fink AK, German RR, Heron M, Stewart SL, Johnson CJ, Finch JL, et al. Impact of using multiple causes of death codes to compute site-specific, death certificate-based cancer mortality statistics in the United States. Cancer Epidemiol. 2012;36(1):22\u20138. https:\/\/doi.org\/10.1016\/j.canep.2011.07.004.","journal-title":"Cancer Epidemiol"},{"key":"3224_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/medicina61050917","volume":"61","author":"IA Nasser","year":"2025","unstructured":"Nasser IA, Asghar S, Masud L, Hafeez MA, Hurjkaliani S, Zulfiqar E, et al. The interplay of cancer and hypertension: rising mortality and widening disparities across the United States (1999\u20132023). Med (Kaunas). 2025;61:917. https:\/\/doi.org\/10.3390\/medicina61050917.","journal-title":"Med (Kaunas)"},{"key":"3224_CR26","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple cause of death data on CDC WONDER [database]. Accessed 2026. https:\/\/wonder.cdc.gov\/"},{"key":"3224_CR27","volume-title":"ICD-10 version: 2010","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. ICD-10 version: 2010. Geneva: World Health Organization; 2010. https:\/\/icd.who.int\/browse10\/2010\/en."},{"issue":"2","key":"3224_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3322\/caac.20066","volume":"60","author":"AMD Wolf","year":"2010","unstructured":"Wolf AMD, Wender RC, Etzioni RB, Thompson IM, D\u2019Amico AV, Volk RJ, et al. American cancer society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70\u201398. https:\/\/doi.org\/10.3322\/caac.20066.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3224_CR29","first-page":"1","volume":"47","author":"RN Anderson","year":"1998","unstructured":"Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 1998;47(3):1\u201316.","journal-title":"Natl Vital Stat Rep"},{"key":"3224_CR30","unstructured":"Ingram DD, Franco SJ. 2013 NCHS urban-rural classification scheme for counties. Vital Health Stat 2. 2014;(166):1\u201373."},{"issue":"194","key":"3224_CR31","first-page":"1","volume":"1","author":"KE Irimata","year":"2022","unstructured":"Irimata KE, Bastian BA, Clarke TC, Curtin SC, Badwe R, Rui P. Guidance for selecting model options in the National Cancer Institute Joinpoint Regression Software. Vital Health Stat. 2022;1(194):1\u201322.","journal-title":"Vital Health Stat"},{"issue":"3","key":"3224_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(20000215)19:3%3C335::AID-SIM336%3E3.0.CO;2-Z.","journal-title":"Stat Med"},{"issue":"29","key":"3224_CR33","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29):3670\u201382. https:\/\/doi.org\/10.1002\/sim.3733.","journal-title":"Stat Med"},{"issue":"9596","key":"3224_CR34","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"8","key":"3224_CR35","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ctrv.2013.03.003","volume":"39","author":"A Pia","year":"2013","unstructured":"Pia A, Vignani F, Attard G, Tucci M, Bironzo P, Scagliotti G, et al. Strategies for managing ACTH-dependent mineralocorticoid excess induced by abiraterone. Cancer Treat Rev. 2013;39(8):966\u201373. https:\/\/doi.org\/10.1016\/j.ctrv.2013.03.003.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"3224_CR36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/UPJ.0000000000000452","volume":"10","author":"M Davis","year":"2023","unstructured":"Davis M, Stephens A, Butaney M, Morrison C, Corsi N, Sood A. Trends in prostate cancer screening in the pre- and peri-COVID-19 pandemic period. Urol Pract. 2023;10(6):631\u20137. https:\/\/doi.org\/10.1097\/UPJ.0000000000000452.","journal-title":"Urol Pract"},{"issue":"17","key":"3224_CR37","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.jacc.2023.02.044","volume":"81","author":"MH Maqsood","year":"2023","unstructured":"Maqsood MH, Talha KM, Minhas AMK, Fudim M, Khan SS, Butler J, et al. CDC-WONDER database analysis of COVID-19 and cardiovascular disease-related mortality. J Am Coll Cardiol. 2023;81(17):1743\u20135. https:\/\/doi.org\/10.1016\/j.jacc.2023.02.044.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3224_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/aje\/kwae154","volume":"194","author":"SY Tai","year":"2025","unstructured":"Tai SY, Kawachi I, Lu TH. Assessing the quality of cause-of-death reporting before and during the COVID-19 pandemic. Am J Epidemiol. 2025;194(1):287\u201394. https:\/\/doi.org\/10.1093\/aje\/kwae154.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"3224_CR39","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/ajh\/hpae108","volume":"37","author":"T Adair","year":"2024","unstructured":"Adair T, Li H, Rao C. Assessing the accuracy of reporting of hypertension on death certificates in Australia. Am J Hypertens. 2024;37(12):948\u201352. https:\/\/doi.org\/10.1093\/ajh\/hpae108.","journal-title":"Am J Hypertens"},{"issue":"2","key":"3224_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jpainsymman.2020.08.026","volume":"61","author":"SH Cross","year":"2021","unstructured":"Cross SH, Kaufman BG, Quest TE, Warraich HJ. National trends in hospice facility deaths in the United States, 2003\u20132017. J Pain Symptom Manage. 2021;61(2):350\u20137. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.08.026.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"3224_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jgo.2020.10.008","volume":"12","author":"R Sedhom","year":"2021","unstructured":"Sedhom R, Kuo PL, Gupta A, Smith TJ, Chino F, Carducci MA, et al. Changes in the place of death for older adults with cancer: reason to celebrate or a risk for unintended disparities? J Geriatr Oncol. 2021;12(3):361\u20137. https:\/\/doi.org\/10.1016\/j.jgo.2020.10.008.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"3224_CR42","doi-asserted-by":"publisher","first-page":"e35606","DOI":"10.1002\/cncr.35606","volume":"131","author":"A Mousa","year":"2025","unstructured":"Mousa A, Nguyen DD, Lalani AK, Satkunasivam R, Aminoltejari K, Hird A, et al. Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: a population-based assessment of adherence to therapeutic monitoring guidelines. Cancer. 2025;131(1):e35606. https:\/\/doi.org\/10.1002\/cncr.35606.","journal-title":"Cancer"},{"issue":"2","key":"3224_CR43","doi-asserted-by":"publisher","first-page":"e210070","DOI":"10.1001\/jamanetworkopen.2021.0070","volume":"4","author":"L Sun","year":"2021","unstructured":"Sun L, Parikh RB, Hubbard RA, Cashy J, Takvorian SU, Vaughn DJ, et al. Assessment and management of cardiovascular risk factors among US veterans with prostate cancer. JAMA Netw Open. 2021;4(2):e210070. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0070.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"3224_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jaccao.2023.05.011","volume":"5","author":"AJ Nelson","year":"2023","unstructured":"Nelson AJ, Lopes RD, Hong H, Hua K, Slovin S, Tan S, et al. Cardiovascular effects of GnRH antagonists compared with agonists in prostate cancer: a systematic review. JACC CardioOncol. 2023;5(5):613\u201324. https:\/\/doi.org\/10.1016\/j.jaccao.2023.05.011.","journal-title":"JACC CardioOncol"},{"issue":"27","key":"3224_CR45","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating NL, O\u2019Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006;24(27):4448\u201356. https:\/\/doi.org\/10.1200\/JCO.2006.06.2497.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3224_CR46","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.amjmed.2010.12.027","volume":"124","author":"AM Traish","year":"2011","unstructured":"Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578\u201387. https:\/\/doi.org\/10.1016\/j.amjmed.2010.12.027.","journal-title":"Am J Med"},{"issue":"4","key":"3224_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.2047-2927.2013.00093.x","volume":"1","author":"AS Cheung","year":"2013","unstructured":"Cheung AS, Pattison D, Bretherton I, Hoermann R, Lim Joon D, Ho E, et al. Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines. Andrology. 2013;1(4):583\u20139. https:\/\/doi.org\/10.1111\/j.2047-2927.2013.00093.x.","journal-title":"Andrology"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-026-03224-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:16:52Z","timestamp":1792595812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-026-03224-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":47,"alternative-id":["3224"],"URL":"https:\/\/doi.org\/10.1007\/s40615-026-03224-3","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used publicly available, de-identified aggregate mortality data from the CDC WONDER Multiple Cause of Death database and did not involve direct contact with human participants or identifiable human data. Institutional review board approval and informed consent were not required for this study. This study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}